ArticleFrontiers in oncology2021

Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine Against HER2 Shows Safety and Preliminary Clinical Efficacy.

Hoyoung M Maeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.